Owners, management and financials
CVR: 45367282
EUR -256,439
Gross profit
Net result: EUR -272,818
CLAUS OLESEN HOLDING ApS (25-33,32%), BODD ApS (25-33,32%)
2 more
CVR · view owners
Lasse Reimer, William Brown
Board: Anker Gunvald Lundemose (chair) and 2 members
CVR · view management
Active
Founded 30 January 2025
CVR · view overview
2 employees
CVR · 2026
Owner registered: PHJ 2025 Holding ApS
CVR · 29/05/2026
View the full event history
Synuca Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2025. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lasse Reimer and William Brown. The board consists of Anker Gunvald Lundemose (chair), Claus Elsborg Olesen and Lasse Reimer. The company's owners include CLAUS OLESEN HOLDING ApS, BODD ApS and PHJ 2025 Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of EUR -256,439 and a net result of EUR -272,818. Equity in the 2025 report amounted to EUR -267,462.
Selskabets formål er at drive virksomhed med forskning og udarbejdelse af stoffer, herunder til medicinalindustrien, samt enhver i forbindelse hermed stående virksomhed
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202530/01/2025 – 31/12/2025 | -256 t. EUR | -273 t. EUR | 345 t. EUR | -267 t. EUR | 1 |
Compared to 1.037 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of Synuca Therapeutics ApS is 45367282.
The owners of Synuca Therapeutics ApS include CLAUS OLESEN HOLDING ApS, BODD ApS and PHJ 2025 Holding ApS.
The management of Synuca Therapeutics ApS consists of Lasse Reimer and William Brown.
The board of Synuca Therapeutics ApS consists of Anker Gunvald Lundemose, Claus Elsborg Olesen and Lasse Reimer, with Anker Gunvald Lundemose as chair.
In 2025, Synuca Therapeutics ApS reported a gross profit of EUR -256,439.
Synuca Therapeutics ApS had 2 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Synuca Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -256,439, and the net result was DKK -272,818.
As of June 29, 2026, Claus Elsborg Olesen has joined the board of directors of Synuca Therapeutics ApS.
As of June 29, 2026, Anker Gunvald Lundemose has joined the board of directors of Synuca Therapeutics ApS.
As of June 29, 2026, Lasse Reimer has joined the board of directors of Synuca Therapeutics ApS.
As of May 29, 2026, PHJ 2025 Holding ApS is registered as an owner of Synuca Therapeutics ApS with an ownership share of 15%.
As of May 29, 2026, Raul Holding ApS is registered as an owner of Synuca Therapeutics ApS with an ownership share of 15%.
As of January 30, 2025, EY Godkendt Revisionspartnerselskab has been appointed auditor of Synuca Therapeutics ApS.
As of January 30, 2025, William Brown is registered as director of Synuca Therapeutics ApS.
As of January 30, 2025, Lasse Reimer is registered as director of Synuca Therapeutics ApS.
As of January 30, 2025, CLAUS OLESEN HOLDING ApS is registered as an owner of Synuca Therapeutics ApS with an ownership share of 25%.
As of January 30, 2025, BODD ApS is registered as an owner of Synuca Therapeutics ApS with an ownership share of 25%.
Synuca Therapeutics ApS was founded on January 30, 2025.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 36465972
CVR 45436497
CVR 46059220
CVR 41978074
CVR 46543912
